A company can be an excellent business and still be a terrible acquisition.
This is one of the most important and least intuitive principles in transaction advisory. The quality of the target and the quality of the deal are entirely different variables. They are evaluated with different tools, governed by different logic and lead to different conclusions. Conflating them is the most common intellectual error in M&A, and it is responsible for more value destruction than overpayment, integration failure or strategic misalignment combined.
A company with strong margins, loyal customers, a capable management team and a defensible market position is a good business. The same company acquired at 15x EBITDA, with limited synergies, high integration complexity, a management team that departs after the earn-out and a competitive response that erodes the market position within 18 months, is a bad acquisition.
The distinction is not semantic. It is economic. And the failure to maintain it is what produces the statistic that the majority of acquisitions fail to generate returns that exceed the acquirer’s cost of capital.
The Decision Arithmetic
Every acquisition decision should be decomposed into five variables:
Standalone value + realisable synergies - integration costs - risk premium - opportunity cost = deal value
Each variable is frequently misjudged, and the direction of the misjudgment is consistently in favour of the deal proceeding.
Standalone value
Standalone value is the present value of the target’s cash flows as an independent entity, without any changes introduced by the acquirer. It is the value the target would have if nobody acquired it.
Buyers routinely overestimate standalone value because they accept the seller’s forward projections without testing their assumptions against historical accuracy, market conditions and management capacity. A company projecting 20% revenue growth for the next five years may have achieved 12% over the prior five. The gap between projection and history is the gap between optimism and evidence.
The forensic discipline required: compare management projections to historical performance for the prior three to five years. Identify every instance where projections exceeded actuals. Calculate the average over-projection. Apply that discount to forward projections. The adjusted figure is the evidenced standalone value.
Realisable synergies
Synergies are the economic benefits that the combination produces which neither company could achieve independently. They come in two varieties, and the distinction matters enormously.
Cost synergies (eliminating duplicated functions, consolidating procurement, rationalising facilities) are more predictable because they are within the acquirer’s control. If two companies each have a finance team of 20, the combined entity probably does not need 40. The synergy is identifiable, quantifiable and achievable through management action.
Revenue synergies (cross-selling to each other’s customers, entering new markets through combined capabilities, leveraging combined brand strength) are less predictable because they depend on customer behaviour, which the acquirer does not control. A customer of Company A may not want to buy Company B’s products simply because the companies merged.
The forensic discipline required: discount revenue synergies by 50% to 70%. Accept cost synergies at 70% to 80% of projected value. Require a named executive accountable for each synergy line item, with a defined timeline and a measurable target.
Integration costs
Integration costs include the direct costs (systems migration, facility rationalisation, redundancy payments, rebranding, legal and advisory fees) and the indirect costs (management distraction, customer uncertainty, cultural friction, talent attrition, operational disruption during transition).
Direct costs are typically underestimated by 20% to 40%. Indirect costs are typically underestimated by 50% to 100%, because they are difficult to quantify and easy to omit from a model that is being built to support the decision to proceed.
Risk premium
Every acquisition carries execution risk. The probability that the deal delivers exactly what was projected is not 100%. It is rarely above 50% for large, complex integrations. A rational buyer should discount the projected returns by the probability of underperformance.
A projected 20% ROIC with a 50% probability of full realisation is an expected return of 10%. If the acquirer’s WACC is 12%, the deal destroys value in expected terms even though it creates value in projected terms.
Opportunity cost
The capital deployed in the acquisition cannot be deployed elsewhere. If the acquirer’s best alternative use of that capital, whether organic growth, debt repayment, share buyback or another acquisition, generates a higher risk-adjusted return, the acquisition destroys value relative to the alternative.
Opportunity cost is the variable most frequently absent from acquisition analysis, because it requires the acquirer to compare the deal not to doing nothing, but to doing the next-best thing. And the next-best thing is almost always less exciting than an acquisition.
Why Good Businesses Become Bad Acquisitions
The winner’s curse
In a competitive auction, the buyer who wins is, by definition, the buyer who was willing to pay the most. If each bidder’s valuation contains some estimation error, the winner is likely the bidder whose estimation error was largest in the upward direction.
Management team departure
Many good businesses are good because of their management teams. An acquisition that values the company at a premium for its management quality but structures the deal in a way that incentivises the management team to leave after two years is buying an asset whose primary value driver has a defined expiry date.
Strategic fit vs operational fit
A target that is strategically complementary may be operationally incompatible. Different cultures, different systems, different decision-making speeds, different quality standards and different customer service philosophies can make two companies that look excellent on a strategy slide dysfunctional as a combined operating entity.
Ashish Chaudhary, Founder and Managing Director of Northrop Management Private Limited, frames the discipline directly: “You are not buying a business. You are buying a business at a price. The quality of the target is a necessary condition for a good acquisition. It is not a sufficient one. The sufficient condition is that the price, net of integration costs, risk and opportunity cost, creates value that exceeds the return available from alternative uses of the same capital.”
The Northrop Perspective
In Northrop Management due diligence and transaction advisory practice, every engagement begins with a question that precedes the financial analysis: should this transaction happen at all?
The diligence process is designed to answer three questions in sequence. First, is the target a good business (operating performance, market position, management quality, revenue quality, customer concentration, operational resilience)? Second, is it a good acquisition at this price (standalone valuation, synergy realisation, integration cost, risk premium, opportunity cost)? Third, what are the conditions under which the acquirer should walk away?
The third question is the most important and the most frequently omitted. A diligence process that does not define walk-away conditions before the analysis begins is a process designed to confirm a decision that has already been made. That is advocacy, not diligence.
Questions for the Boardroom
- For our most recent acquisition, did we calculate the deal value using all five variables (standalone value, synergies, integration costs, risk premium, opportunity cost), or did we evaluate it on projected returns alone?
- What was the realised ROIC on our acquisitions over the last five years, and how did it compare to the projected ROIC at the time of approval?
- Did we define explicit walk-away conditions before commencing diligence, and were those conditions tested during the process?
- What was the opportunity cost of the capital we deployed in our last acquisition, measured against the next-best alternative use?
- If the management team of our most recent acquisition departs at the end of their retention period, what happens to the revenue, margins and customer relationships that justified the purchase price?
Closing Implication
The quality of a business and the quality of an acquisition are independent variables. A board that approves an acquisition because the target is an excellent company has answered the wrong question. The right question is whether the acquisition, at this price, net of all costs and risks, creates more value than the alternative uses of the same capital.
The discipline to ask that question, and to walk away when the answer is no, is the single most valuable capability a board can develop in its approach to M&A. And it is the capability most consistently absent.
